Qingwei Ji Selected Research

WD repeat containing planar cell polarity effector

5/2022	Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress.
3/2020	Expression of Sfrp5/Wnt5a in human epicardial adipose tissue and their relationship with coronary artery disease.
10/2019	High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
1/2019	Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.
10/2017	Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingwei Ji Research Topics

Disease

14	Atherosclerosis 05/2022 - 10/2012
9	Hypertension (High Blood Pressure) 07/2021 - 02/2015
8	Inflammation (Inflammations) 05/2022 - 03/2010
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 10/2017
6	Aortic Dissection 12/2020 - 11/2018
6	Myocardial Infarction 01/2020 - 01/2012
4	Acute Coronary Syndrome 09/2020 - 01/2014
4	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2017
4	Stable Angina 11/2014 - 01/2012
3	Heart Failure 11/2021 - 08/2015
3	Obesity 10/2020 - 01/2016
3	ST Elevation Myocardial Infarction 01/2020 - 01/2015
3	Chest Pain (Chest Pains) 01/2020 - 01/2012
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 10/2019 - 01/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2010
3	Unstable Angina 11/2014 - 01/2012
2	Fibrosis (Cirrhosis) 07/2021 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 10/2020 - 09/2015
2	Neoplasms (Cancer) 01/2020 - 06/2018
2	Heart Diseases (Heart Disease) 01/2019 - 09/2018
2	Thoracic Aorta Dissection 11/2018 - 06/2018
2	Insulin Resistance 10/2017 - 06/2016
1	Aneurysm (Aneurysms) 01/2022
1	Sepsis (Septicemia) 01/2021
1	Abdominal Aortic Aneurysm 12/2020
1	Myocarditis (Carditis) 12/2020
1	Overweight 10/2020
1	Respiratory Insufficiency (Respiratory Failure) 10/2020
1	Hypoxia (Hypoxemia) 10/2020
1	Carotid Artery Diseases 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Reperfusion Injury 10/2019
1	Type 2 Diabetes Mellitus (MODY) 08/2019
1	Heart Injuries 06/2018
1	Ischemia 06/2018
1	Hypertrophy 01/2017
1	Pathologic Constriction (Stenosis) 06/2016
1	Diabetes Mellitus 01/2016
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2015
1	Vascular Calcification 07/2015

Drug/Important Bio-Agent (IBA)

9	Apolipoproteins E (ApoE)IBA 05/2022 - 10/2012
9	InterleukinsIBA 01/2022 - 01/2014
9	CytokinesIBA 01/2020 - 01/2012
6	Angiotensin IIIBA 12/2020 - 02/2015
6	Interleukin-22 (IL-22)IBA 01/2020 - 01/2017
5	WD repeat containing planar cell polarity effectorIBA 05/2022 - 10/2017
4	Messenger RNA (mRNA)IBA 06/2021 - 06/2016
4	AdipokinesIBA 03/2020 - 11/2014
4	Interleukin-12 Subunit p35IBA 01/2020 - 09/2018
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
4	Interleukin-12 (IL 12)IBA 01/2020 - 01/2012
3	Neutralizing AntibodiesIBA 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2015
3	Interleukin-16 (Interleukin 16)IBA 01/2022 - 01/2021
3	Interleukin-27 (Interleukin 27)IBA 01/2020 - 01/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	Troponin T (Troponin T1)IBA 01/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2016
2	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2015
2	Interleukin-23 (Interleukin 23)IBA 01/2020 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2019 - 01/2016
2	Interleukin-11 (Interleukin 11)IBA 01/2019 - 06/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2015
2	CollagenIBA 01/2018 - 12/2017
2	Insulin (Novolin)FDA Link 10/2017 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2017 - 01/2017
2	AdiponectinIBA 06/2016 - 11/2014
2	oxidized low density lipoproteinIBA 09/2015 - 10/2012
2	EnzymesIBA 08/2015 - 11/2014
2	ImmunosorbentsIBA 08/2015 - 11/2014
1	Interleukin-9 (Interleukin 9)IBA 07/2021
1	N 30IBA 06/2021
1	MB Form Creatine KinaseIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Extracellular Matrix ProteinsIBA 12/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	Oxygen (Dioxygen)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	6-methyladenineIBA 09/2020
1	Biological ProductsIBA 01/2020
1	NAD (NADH)IBA 06/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Triglycerides (Triacylglycerol)IBA 10/2017
1	interleukin-22 receptor (IL-22R)IBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	HDL CholesterolIBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 09/2015
1	Blood Group Antigens (Blood Groups)IBA 09/2015
1	ApolipoproteinsIBA 07/2015

Therapy/Procedure

2	Endovascular Aneurysm Repair 12/2019 - 08/2019
2	Percutaneous Coronary Intervention 10/2019 - 01/2016
1	Cardiac Resynchronization Therapy 11/2021
1	Ligation 01/2021
1	Punctures 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Drug-Eluting Stents 01/2016